Despite ongoing supply chain disruption, the Group has reported results in-line with expectation. Adjusted EBITDA from continuing operations improved slightly to £12.7m with the Energy divisions growing by c.15%. Increased investment in the Medical division and the pivot away from 3rd party component manufacture resulted in an offsetting c.£1.5m EBITDA movement. The Group enters FY2023 with a robust order book that already provides 90% coverage for FY23E and 45% for FY24E. Our EBITDA forecasts r ....

28 Sep 2022
In-line results, robust outlook

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
In-line results, robust outlook
Avingtrans plc (AVG:LON) | 375 0 0.0% | Mkt Cap: 123.3m
- Published:
28 Sep 2022 -
Author:
Richard Hickinbotham -
Pages:
3 -
Despite ongoing supply chain disruption, the Group has reported results in-line with expectation. Adjusted EBITDA from continuing operations improved slightly to £12.7m with the Energy divisions growing by c.15%. Increased investment in the Medical division and the pivot away from 3rd party component manufacture resulted in an offsetting c.£1.5m EBITDA movement. The Group enters FY2023 with a robust order book that already provides 90% coverage for FY23E and 45% for FY24E. Our EBITDA forecasts r ....